Performance Highlights - H1 FY27

Financial Performance (Consolidated, ₹ crores):

  • Revenue from Operations: ₹48.9 crore, up 8% YoY from ₹45.2 crore in H1 FY26
  • Operating Expense + Cost of Material Consumed: ₹20.5 crore, up 23% YoY
  • Employee Benefits Expense: ₹5.1 crore, up 23% YoY
  • Other Expenses: ₹9.3 crore, up 30% YoY
  • EBITDA: ₹14.1 crore, down 18% YoY
  • EBITDA Margin: 28.9%, declined 936 bps from 38.2% in H1 FY26
  • Finance Costs: ₹0.33 crore, reduced 74% YoY
  • Profit Before Tax: ₹10.7 crore, down 21% YoY
  • Profit After Tax: ₹7.8 crore, down 22% YoY
  • PAT Margin: 16.0%, declined 623 bps from 22.2% in H1 FY26

Service-wise Revenue Breakdown (H1 FY27):

  • Radiology: ₹39.7 crore (6% YoY growth)
  • Pathology: ₹7.6 crore (17% YoY growth)
  • Cardiology: ₹1.3 crore (22% YoY growth)
  • Neurology: ₹0.2 crore (20% YoY growth)
  • Urology: ₹0.1 crore (47% YoY growth)
  • Total: ₹48.9 crore

Balance Sheet Position (H1 FY27, ₹ crores):

  • Total Assets: ₹150.9 crore
  • Property, Plant and Equipment: ₹28.6 crore
  • Trade Receivables: ₹64.0 crore
  • Cash & Cash Equivalents: ₹26.0 crore
  • Total Shareholders' Equity: ₹123.9 crore
  • Long-term Borrowings: ₹2.5 crore
  • Short-term Borrowings: ₹11.9 crore

Cash Flow Statement (H1 FY27, ₹ crores):

  • Net Cash from Operating Activities: (₹6.2) crore
  • Net Cash from Investing Activities: (₹12.8) crore
  • Net Cash from Financing Activities: (₹6.6) crore
  • Net Decrease in Cash: (₹25.6) crore

Operational and Business Updates

Business Model Reclassification:

  • One business previously classified under B2C has been correctly reclassified under B2B
  • Current business model segments: B2G (government and PPP), B2B (hospital tie-ups), B2C (direct-to-patient)

Network Expansion:

  • B2B hospital tie-up network expanded by 40-45 additional hospitals
  • Total B2B network now stands at 150+ tie-ups
  • Geographic presence: Delhi, Uttar Pradesh, Maharashtra (Nasik)

Technology Enhancements:

  • Installed high-end 640-slice CT scanner to enhance advanced imaging capabilities
  • Implementing ERP system to streamline operations, accounting, and inter-department integration
  • IT tools include LIS, PACS, Augnito (Voice AI), Tally, SanCCS (Call Center), Freedom Modality
  • Specialized tools: Motic (Cytology Imaging), Priscca (Double/Triple Marker Testing)

PPP Operations:

  • B2G revenue: ₹1.7 crores through royalty-based model
  • Collaborating with governments of Uttar Pradesh, Delhi, and Nashik under PPP model
  • Set up Radiology Unit with 1.5T MRI and 16-slice CT scan machine in Delhi
  • Three PPP projects currently in pipeline for execution

Growth Strategy and Future Plans

Near-term Initiatives:

  • Commissioning of full-fledged Dwarka diagnostic centre by end-November 2026 (subject to PCPNDT approval)
  • Expected annual revenue from Dwarka centre: ₹5-6 crore in initial years
  • Equipment: CT scan, MRI, ultrasound, X-ray facilities

Expansion Plans:

  • Expand RG Stone collaboration with additional CT scan facility in Faridabad
  • Expand diagnostic network into Gurgaon and Noida
  • Increase MRI capacity at Tilak Nagar
  • Establish dedicated laboratory infrastructure for genome sequencing

Capital Expenditure:

  • Planned FY27 capex: ₹20-25 crore towards diagnostic equipment and centre construction
  • Supporting company's 20-25% annual revenue growth ambition

Debt Position:

  • Progressing towards debt-free position
  • Two loans fully repaid during the period
  • Significant decline in interest expenses

Management Commentary

  • Growth driven by stronger B2B partnerships, rising B2C activity, and improved operational efficiencies across existing centres
  • Enhanced operational efficiency and capacity utilisation across existing diagnostic centres
  • Strengthening B2C contribution to reduce dependence on government receivables and support positive operating cash flows
  • Making diagnostic services available to broader population through government collaborations

Leadership Team

  • Mr. Pawan Gupta: Chairman and Managing Director (B.Com from Dr. Bhimrao Ambedkar University, 2000)
  • Dr. Sameer Sood: Non-Executive Director (Radiologist with 28 years association, MD Radio-Diagnosis from AIIMS)
  • Ms. Neelam Ratra: Executive Director (MBA in Hospital Administration, previously with Ayushman Hospital)
  • Ms. Chhaya Gupta: Executive Director (MBA in International Business Management, 7.5 years experience)